An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 009170
Company: VALEANT

Medication Guide

Products on NDA 009170

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MYSOLINE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	AB	Yes	No
MYSOLINE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 009170

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/08/1954	ORIG-1	Approval	Type 1 - New Molecular Entity	PRIORITY		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/10/2020	SUPPL-40	Manufacturing (CMC)-Facility	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/009170Orig1s040ltr.pdf
02/19/2016	SUPPL-39	Manufacturing (CMC)		Label is not available on this site.
08/10/2011	SUPPL-38	REMS-Modified	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/009170s038ltr.pdf
04/23/2009	SUPPL-36	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/009170s036lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/009170s036ltr.pdf
07/21/2010	SUPPL-35	REMS-Proposal, Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009170s035lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/009170s035ltr.pdf
05/08/2009	SUPPL-34	Labeling-Package Insert, Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/09170_S034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/009170s034ltr.pdf
01/29/2009	SUPPL-33	Manufacturing (CMC)	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/009170s033ltr.pdf
06/13/2008	SUPPL-31	Labeling-Container/Carton Labels, Labeling-Package Insert	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/009170s031ltr.pdf
05/06/2002	SUPPL-21	Manufacturing (CMC)		Label is not available on this site.
12/14/2000	SUPPL-20	Manufacturing (CMC)		Label is not available on this site.
04/10/2000	SUPPL-19	Labeling		Label is not available on this site.
03/18/1994	SUPPL-18	Manufacturing (CMC)-Control		Label is not available on this site.
10/25/1989	SUPPL-17	Manufacturing (CMC)		Label is not available on this site.
07/28/1988	SUPPL-16	Manufacturing (CMC)-Packaging		Label is not available on this site.
09/02/1987	SUPPL-14	Manufacturing (CMC)-Control		Label is not available on this site.
08/11/1989	SUPPL-13	Manufacturing (CMC)-Formulation		Label is not available on this site.
05/20/1982	SUPPL-12	Manufacturing (CMC)-Control		Label is not available on this site.
01/28/1982	SUPPL-11	Manufacturing (CMC)-Control		Label is not available on this site.
02/18/1981	SUPPL-7	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 009170

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/10/2020	SUPPL-40	Manufacturing (CMC)-Facility	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/009170Orig1s040lbl.pdf
07/21/2010	SUPPL-35	REMS-Proposal	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009170s035lbl.pdf
07/21/2010	SUPPL-35	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009170s035lbl.pdf
05/08/2009	SUPPL-34	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/09170_S034lbl.pdf
05/08/2009	SUPPL-34	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/09170_S034lbl.pdf
04/23/2009	SUPPL-36	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/009170s036lbl.pdf

Therapeutic Equivalents for NDA 009170

MYSOLINE

TABLET;ORAL; 250MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MYSOLINE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	Yes	AB	009170	VALEANT
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	040866	AMNEAL PHARM
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	040626	ANDA REPOSITORY
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	218366	CARNEGIE
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	084903	LANNETT
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	040586	OXFORD PHARMS
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	214896	RUBICON
PRIMIDONE	PRIMIDONE	250MG	TABLET;ORAL	Prescription	No	AB	083551	WATSON LABS

TABLET;ORAL; 50MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MYSOLINE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	Yes	AB	009170	VALEANT
PRIMIDONE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	No	AB	040866	AMNEAL PHARM
PRIMIDONE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	No	AB	040626	ANDA REPOSITORY
PRIMIDONE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	No	AB	218366	CARNEGIE
PRIMIDONE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	No	AB	084903	LANNETT
PRIMIDONE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	No	AB	040586	OXFORD PHARMS
PRIMIDONE	PRIMIDONE	50MG	TABLET;ORAL	Prescription	No	AB	214896	RUBICON

Top